Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline in Thyroid Associated Ophthalmopathy
NCT05112211Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of doxycycline in thyroid associated ophthalmopathy (TAO), sponsored by Sun Yat-sen University. Primary endpoint: Change of extraocular muscle volume and orbital fat volume by MRI at 6 months. Started Jan 2022; status: recruiting.
02
Drugs
doxycycline
03
Conditions
thyroid associated ophthalmopathy (TAO)
Beyond the preview
Go deeper on NCT05112211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05112211.